Effect of normal human serum on the binding of specific antibodies and platelet-unrelated immune complexes to human platelets.
Radiolabelled staphylococcal protein A was used to quantitate the binding of IgG on stored human platelets from human sera containing specific antibodies reactive with platelets and rabbit serum containing immune complexes (IC). Normal human serum (NHS) inhibited the binding of IC onto platelets and to various extents also the binding of specific antibodies. The attachment of inhibitors to platelets seemed to be reversible. The considerable difference in the inhibitory capacities of IgG-deficient sera and monomeric IgG indicates that IgG is the major inhibitory component of NHS. The binding of IgG from NHS onto platelets evidently hampers the detection of weak platelet antibodies even with the most sensitive tests. Purified Clq, known to modify the reactions of IC with fresh platelets did not alter the binding of IC onto stored platelets. A monoclonal, antiglobulin-active rheumatoid factor of IgM class displayed only moderate inhibition. Therefore, the application of RF or Clq for the differentiation of the binding induced by IC or antibodies is not useful in this assay system. The heterogeneity of immunologic receptors of platelets provides an explanation of the inhibitory inefficiency of Clq.
D000328:Adult; D000918:Antibody Specificity; D000936:Antigen-Antibody Complex; D001666:Binding Sites, Antibody; D001769:Blood; D001792:Blood Platelets / Q000276:immunology*; D002478:Cells, Cultured; D003172:Complement C1 / Q000008:administration & dosage; D003470:Culture Media; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D012217:Rheumatoid Factor / Q000008:administration & dosage; D013205:Staphylococcal Protein A / Q000276:immunology
D000936:Antigen-Antibody Complex; D003172:Complement C1; D003470:Culture Media; D007074:Immunoglobulin G; D013205:Staphylococcal Protein A; D012217:Rheumatoid Factor